Clinical Trial Update: PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION [Phase 2, Phase 3]

View source ↗

Summary

The PROVOCATION trial studied prophylactic intravenous hydration to prevent contrast-induced kidney injury and has completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Kidney Failure, Acute | Phase 2, Phase 3 | Status: COMPLETED